NASDAQ:ONCT Oncternal Therapeutics (ONCT) News Today $0.30 -0.01 (-3.22%) (As of 10/3/2023 ET) Add Compare Share Share Today's Range$0.30▼$0.3250-Day Range$0.29▼$0.4052-Week Range$0.26▼$1.33Volume163,658 shsAverage Volume332,023 shsMarket Capitalization$17.71 millionP/E RatioN/ADividend YieldN/APrice Target$4.10 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineStockNews.com Begins Coverage on Oncternal Therapeutics (NASDAQ:ONCT)americanbankingnews.com - September 28 at 3:16 AMHC Wainwright & Co. Upgrades Oncternal Therapeutics (ONCT)msn.com - September 18 at 5:48 PMAnalysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Innate Pharma (IPHA)markets.businessinsider.com - September 18 at 7:34 AMWe're A Little Worried About Oncternal Therapeutics' (NASDAQ:ONCT) Cash Burn Ratefinance.yahoo.com - September 17 at 9:56 AMCantor Fitzgerald Reiterates Oncternal Therapeutics (ONCT) Neutral Recommendationmsn.com - September 9 at 4:58 AMOncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Boardfinance.yahoo.com - September 7 at 10:16 AMQ2 2023 Oncternal Therapeutics Inc Earnings Callfinance.yahoo.com - August 12 at 3:51 PMOncternal Therapeutics Provides Business Update and Announces Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 11 at 3:07 AMWhat Wall Street expects from Oncternal Therapeutics's earningsmarkets.businessinsider.com - August 9 at 1:28 PMOncternal Therapeutics Receives FDA Study May Proceed Letter for ONCT-534, its Novel Dual-action Androgen Receptor Inhibitor, for the Treatment of Patients with Advanced Prostate Cancerfinance.yahoo.com - August 3 at 5:46 PMOncternal Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 3 at 5:46 PMONCT - Oncternal Therapeutics, Inc.finance.yahoo.com - July 27 at 12:11 AMKyowa Kirin Appoints Gunnar F. Kaufmann, Ph.D., as Chief Research Officer, North Americamarkets.businessinsider.com - June 21 at 12:49 PMOncternal Therapeutics Inc ONCT Stock Quotemorningstar.com - June 10 at 3:04 PMOncternal Therapeutics Announces First Patient Dosed in Phase 1/2 Study of ROR1 targeting autologous CAR T, ONCT-808, in patients with relapsed or refractory aggressive B-cell lymphomafinance.yahoo.com - June 8 at 6:33 PMHC Wainwright & Co. Reiterates Oncternal Therapeutics (ONCT) Neutral Recommendationmsn.com - June 6 at 4:20 PMH.C. Wainwright Sticks to Its Hold Rating for Oncternal Therapeutics (ONCT)markets.businessinsider.com - June 6 at 8:15 AMOncternal Therapeutics to Participate at the 2023 Jefferies Healthcare Conferencefinance.yahoo.com - May 31 at 8:45 PMBTIG Sticks to Their Buy Rating for Shattuck Labs (STTK)markets.businessinsider.com - May 10 at 9:12 AMBTIG Keeps Their Buy Rating on Xencor (XNCR)markets.businessinsider.com - May 9 at 7:55 AMOncternal Therapeutics First Quarter 2023 Earnings: Revenues Beat Expectations, EPS In Linefinance.yahoo.com - May 6 at 8:30 AMOncternal Therapeutics GAAP EPS of -$0.20 in-line, revenue of $0.2M beats by $0.06Mmsn.com - May 4 at 8:00 PMOncternal Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Resultsfinance.yahoo.com - May 4 at 8:00 PMOncternal Therapeutics: Q1 Earnings Insightsmsn.com - May 4 at 8:00 PMOncternal Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Resultsfinance.yahoo.com - May 4 at 8:00 PMWill Nektar Therapeutics (NKTR) Report Negative Earnings Next Week? What You Should Knowuk.finance.yahoo.com - May 2 at 1:26 PMOncternal Therapeutics to Provide Business Update and Report First Quarter 2023 Financial Resultsfinance.yahoo.com - April 27 at 8:21 PMOncternal Therapeutics Participating in Oppenheimer & Co.’s Virtual Fireside Chat: Discussion of ROR1 CAR T Cell Therapy in Hematological Malignancies and Solid Tumorsfinance.yahoo.com - April 13 at 6:40 PMOncternal Therapeutics Shares Plummet 52% As it Will Close Two Zilovertamab Studiesmarketwatch.com - April 5 at 8:51 AMBrookline Capital Downgrades Oncternal Therapeutics (ONCT)msn.com - April 5 at 8:51 AMOppenheimer Downgrades Oncternal Therapeutics (ONCT)msn.com - April 5 at 8:51 AMOncternal Craters after Halting Two Clinical Studiesmsn.com - April 4 at 7:55 PMOncternal Therapeutics Heads for All-Time Low on Closing of 2 Zilovertamab Studiesmarketwatch.com - April 4 at 2:54 PMOncternal (ONCT) Down on Restructuring Plan to Extend Runwaymsn.com - April 4 at 2:54 PMWhy AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarketmsn.com - April 4 at 9:54 AMOncternal Therapeutics (ONCT) was downgraded to a Hold Rating at H.C. Wainwrightmarkets.businessinsider.com - April 4 at 9:54 AMWhy Is Oncternal Therapeutics (ONCT) Stock Down 62% Today?msn.com - April 4 at 9:54 AMStocks to Watch: Histogen, Exela Technologies, Oncternal Therapeuticsmarketwatch.com - April 4 at 12:15 AMOncternal Therapeutics Announces Strategic Reprioritization and Capital Preservation, Extends Cash Runway into 2025benzinga.com - April 3 at 7:15 PMOncternal Therapeutics Announces Strategic Reprioritization and Capital Preservation, Extends Cash Runway into 2025finance.yahoo.com - April 3 at 7:15 PMmarketbeat.com - April 3 at 4:03 PMCompanies Like Oncternal Therapeutics (NASDAQ:ONCT) Could Be Quite Riskyfinance.yahoo.com - April 2 at 2:20 PMOncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - March 27 at 12:27 PMAnalysts Offer Insights on Healthcare Companies: Oncternal Therapeutics (ONCT) and Viracta Therapeutics (VIRX)markets.businessinsider.com - March 14 at 9:18 AMOncternal Therapeutics, Inc. (ONCT) Q4 2022 Earnings Call Transcriptseekingalpha.com - March 11 at 11:04 PMAnalysts Are Bullish on Top Healthcare Stocks: Oncternal Therapeutics (ONCT), Helius Medical Technologies (HSDT)markets.businessinsider.com - March 11 at 8:24 AMOncternal Therapeutics GAAP EPS of -$0.20 beats by $0.01, revenue of $0.17M misses by $0.11Mmsn.com - March 9 at 6:25 PMOncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2022 Financial Resultsfinance.yahoo.com - March 9 at 6:25 PMOncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Resultsfinance.yahoo.com - March 2 at 7:27 PMOncternal Therapeutics (ONCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Releasemsn.com - March 2 at 2:27 PM Get Oncternal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCT and its competitors with MarketBeat's FREE daily newsletter. Email Address ONCT Media Mentions By Week ONCT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONCT News Sentiment▼0.930.68▲Average Medical News Sentiment ONCT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONCT Articles This Week▼11▲ONCT Articles Average Week Get Oncternal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VIRI News HEPA News ALZN News MBIO News ACST News CNTX News CBIO News PPBT News NRXP News EDSA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:ONCT) was last updated on 10/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncternal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.